Heard

Sign InJoin Heard

Legislative record

SB 49STATE · HawaiiIntroduced

RELATING TO TERMINAL ILLNESSES.

Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions. Effective 12/31/2050. (SD1)

Voted 12/8/2025View source

Roll-call record

How representatives voted

5 yea·0 nay

Docket history

Action history

  1. 12/8/2025Carried over to 2026 Regular Session.
  2. 2/7/2025Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/JDC.
  3. 2/7/2025Reported from HHS (Stand. Com. Rep. No. 90) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/JDC.
  4. 1/29/2025The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
  5. 1/24/2025The committee(s) on HHS has scheduled a public hearing on 01-29-25 1:00PM; Conference Room 225 & Videoconference.
  6. 1/16/2025Referred to HHS, CPN/JDC.
  7. 1/15/2025Introduced and passed First Reading.
  8. 1/8/2025Pending Introduction.